Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
X0400873	20/80混合重组人胰岛素注射液		Injection	Biological Products(7)	New Drug Application	2004-02-23	通化东宝药业股份有限公司	Tonghua Dongbao Pharmaceutical Co Ltd	Certificate Issued	2004-10-15	view
CYSS0600071	30/70双时相低精蛋白锌重组人胰岛素注射液	human insulin;isophane protamine human insulin	Injection	Biological Products(15)	Generic Drug	2006-08-08	江苏万邦生化医药股份有限公司	Wanbang Biopharmaceuticals	Certificate Issued	2007-09-19	view
CYSS0690004	30/70双时相低精蛋白锌重组人胰岛素注射液	human insulin;isophane protamine human insulin	Injection	Biological Products(15)	Generic Drug	2006-10-23	江苏万邦生化医药股份有限公司	Wanbang Biopharmaceuticals	Certificate Issued	2010-03-11	view
CYSL0500005	30/70双时相低精蛋白锌重组人胰岛素注射液	human insulin;isophane protamine human insulin	Injection	Biological Products(15)	Generic Drug	2005-08-24	江苏万邦生化医药股份有限公司	Wanbang Biopharmaceuticals	Certificate Issued	2006-07-12	view
X0305517	30/70混合重组人胰岛素注射液	human insulin	Injection	Biological Products	Supplementary Application	2003-11-05	通化东宝药业股份有限公司	Tonghua Dongbao Pharmaceutical Co Ltd	Certificate Issued	2004-07-26	view
CSb20020075	30/70混合重组人胰岛素注射液	human insulin	Injection	Biological Products(4)	Supplementary Application	2002-06-10	通化东宝药业股份有限公司	Tonghua Dongbao Pharmaceutical Co Ltd	Certificate Issued	2003-02-24	view
CYSB0600113	30/70混合重组人胰岛素注射液	human insulin	Injection	Biological Products	Supplementary Application	2007-03-12	通化东宝药业股份有限公司	Tonghua Dongbao Pharmaceutical Co Ltd	Certificate Issued	2008-01-29	view
CXSL0900023	30/70混合重组人胰岛素注射液	human insulin	Injection	Biological Products(15)	New Drug Application	2009-11-10	浙江海正药业股份有限公司	Zhejiang Hisun Pharmaceutical Co Ltd	Certificate Issued	2011-08-03	view
CYSB0700117	30／70混合重组人胰岛素注射液	human insulin	Injection	Biological Products	Supplementary Application	2008-08-28	通化东宝药业股份有限公司	Tonghua Dongbao Pharmaceutical Co Ltd	Certificate Issued	2009-06-19	view
CXSS0900007	40/60混合重组人胰岛素注射液	human insulin;isophane protamine human insulin	Injection	Biological Products(7)	New Drug Application	2009-08-06	通化东宝药业股份有限公司	Tonghua Dongbao Pharmaceutical Co Ltd	Certificate Issued	2014-03-04	view
X0400874	40/60混合重组人胰岛素注射液	human insulin;isophane protamine human insulin	Injection	Biological Products(7)	New Drug Application	2004-02-23	通化东宝药业股份有限公司	Tonghua Dongbao Pharmaceutical Co Ltd	Certificate Issued	2004-10-15	view
CYSS0690003	50/50混合重组人胰岛素注射液	human insulin	Injection	Biological Products(15)	Generic Drug	2006-10-23	通化东宝药业股份有限公司	Tonghua Dongbao Pharmaceutical Co Ltd	Certificate Issued	2008-02-22	view
Y0402792	50/50混合重组人胰岛素注射液	human insulin	Injection	Biological Products(15)	Generic Drug	2004-04-26	通化东宝药业股份有限公司	Tonghua Dongbao Pharmaceutical Co Ltd	Certificate Issued	2004-10-15	view
J0300366	NPH重组人胰岛素注射液		Injection	Chemical Drugs	License Renew	2003-04-08			Certificate Issued	2003-12-22	view
CSS00070	中性重组人胰岛素注射液		Injection	Biological Products(2)	New Drug Application	2000-09-28	徐州万邦生化制药有限公司	Wanbang Biopharmaceuticals	Approval Completed-Pending Certificated	2002-01-14	view
J0300367	中效人胰岛素注射液		Injection	Chemical Drugs	License Renew	2003-04-08			Certificate Issued	2003-12-22	view
HS20020002	中效人胰岛素注射液		Injection	Biological Products	Import Drug Application	2002-02-05	美国礼来亚洲公司北京办事处		Approval Completed-Pending Certificated	2002-12-05	view
HS20010017	中效人胰岛素注射液		Injection	Biological Products	Import Drug Application	2001-12-27	美国礼来亚洲公司北京办事处		Approval Completed-Pending Certificated	2003-01-29	view
JYSB2000499	人胰岛素注射液	human insulin	Injection	Biological Products(3.1)	Supplementary Application	2020-09-30	丹麦诺和诺德公司	Novo Nordisk A/S	Certificate Issued	2020-12-30	view
JYSB2000651	人胰岛素注射液	human insulin	Injection	Biological Products	Supplementary Application	2020-12-25	丹麦诺和诺德公司	Novo Nordisk A/S	In Review	2020-12-23	view